Dyslipidemia
4 competing products in clinical development for Dyslipidemia.
Pipeline by Phase
Pre-clinical1
Phase 11
Phase 31
Approved1
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Pitavastatin + Pravastatin | Eli Lilly | Approved | Completed | 43 |
| YH14755 + Metformin + Rosuvastatin | Yuhan | Phase 3 | Completed | 40 |
| YHR1705 + YHR1706 + YHR1705+YHR1706 | Yuhan | Phase 1 | Completed | 29 |
| Mevalotin | Daiichi Sankyo | Pre-clinical | Completed | 26 |